The prediction model comprised 15 variables, including age, KPS, NSE, PLR, lymphocyte count, ALP, smoking history, intrathoracic metastasis, metastases to other sites, N_stage, M_stage, surgery for primary lung cancer foci, chemotherapy, EGFR mutation, and TKI treatment. This evidence concerns the gene ENO2 and lung carcinoma.